Stay updated on Pembrolizumab for Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Head and Neck Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-23T02:13:11.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has removed a detailed citation regarding a study on pembrolizumab and cetuximab for head and neck cancer, which is a significant loss of core content.
    Difference
    0.2%
    Check dated 2025-05-15T21:13:21.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T06:25:27.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to include new identifiers and drug information related to recurrent head and neck cancer, while significant details about the clinical trial and treatment options have been removed.
    Difference
    9%
    Check dated 2025-04-16T20:35:39.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T14:36:24.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-02T00:19:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.